{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T10:23:39Z","timestamp":1778495019251,"version":"3.51.4"},"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2015,2,3]],"date-time":"2015-02-03T00:00:00Z","timestamp":1422921600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0116768","type":"journal-article","created":{"date-parts":[[2015,2,3]],"date-time":"2015-02-03T18:53:43Z","timestamp":1422989623000},"page":"e0116768","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":23,"title":["Circulating MiRNA-122 Levels Are Associated with Hepatic Necroinflammation and Portal Hypertension in HIV\/HCV Coinfection"],"prefix":"10.1371","volume":"10","author":[{"given":"Christian","family":"Jansen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Reiberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah","family":"Eischeid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Schierwagen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mattias","family":"Mandorfer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evrim","family":"Anadol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Schwabl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolynne","family":"Schwarze-Zander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ute","family":"Warnecke-Eberz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian P.","family":"Strassburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen K.","family":"Rockstroh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Peck-Radosavljevic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margarete","family":"Odenthal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonel","family":"Trebicka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,2,3]]},"reference":[{"key":"ref1","unstructured":"UNAIDS (2013) in Global Report 2013."},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1001\/jama.285.10.1308","article-title":"Survival after AIDS diagnosis in adolescents and adults during the treatment era, United States, 1984\u20131997","volume":"285","author":"LM Lee","year":"2001","journal-title":"JAMA"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0140-6736(03)13802-0","article-title":"Decline in the AIDS and death rates in the EuroSIDA study: an observational study","volume":"362","author":"A Mocroft","year":"2003","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1097\/QAD.0000000000000377","article-title":"Mortality in HIV-hepatitis C co-infected patients in Canada compared to the general Canadian population (2003\u20132013)","volume":"28","author":"MB Klein","year":"2014","journal-title":"AIDS"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s10519-013-9593-y","article-title":"The genetic architecture of liver enzyme levels: GGT, ALT and AST","volume":"43","author":"JH van Beek","year":"2013","journal-title":"Behav Genet"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Marcellin F, Lorente N, Demoulin B, Carrieri MP, Suzan-Monti M, et al. (2014) Comparison of risk factors in HIV-infected men who have sex with men, coinfected or not with hepatitis C virus (ANRS VESPA2 French cross-sectional national survey). Sex Transm Infect.","DOI":"10.1136\/sextrans-2014-051542"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1086\/427216","article-title":"Influence of liver fibrosis on highly active antiretroviral therapy-associated hepatotoxicity in patients with HIV and hepatitis C virus coinfection","volume":"40","author":"L Aranzabal","year":"2005","journal-title":"Clin Infect Dis"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/j.1365-2893.2009.01197.x","article-title":"HIV-HCV co-infected patients with low CD4+ cell nadirs are at risk for faster fibrosis progression and portal hypertension","volume":"17","author":"T Reiberger","year":"2010","journal-title":"J Viral Hepat"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"369","DOI":"10.7326\/M13-1829","article-title":"Hepatic decompensation in antiretroviral-treated patients co-infected with HIV and hepatitis C virus compared with hepatitis C virus-monoinfected patients: a cohort study","volume":"160","author":"Re V Lo 3rd","year":"2014","journal-title":"Ann Intern Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/QAD.0000000000000005","article-title":"HIV\/hepatitis C virus-coinfected patients who achieved sustained virological response are still at risk of developing hepatocellular carcinoma","volume":"28","author":"N Merchante","year":"2014","journal-title":"AIDS"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1055\/s-2005-864780","article-title":"Treatment of chronic hepatitis C in human immunodeficiency virus\/hepatitis C virus-coinfected patients in the era of pegylated interferon and ribavirin","volume":"25","author":"N Brau","year":"2005","journal-title":"Semin Liver Dis"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"815","DOI":"10.3851\/IMP1831","article-title":"Considerable under-treatment of chronic HCV infection in HIV patients despite acceptable sustained virological response rates in a real-life setting","volume":"16","author":"T Reiberger","year":"2011","journal-title":"Antivir Ther"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/hep.20626","article-title":"HIV coinfection shortens the survival of patients with hepatitis C virus-related decompensated cirrhosis","volume":"41","author":"JA Pineda","year":"2005","journal-title":"Hepatology"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"7366","DOI":"10.1128\/JVI.00191-09","article-title":"Coinfection with hepatitis C virus and human immunodeficiency virus: virological, immunological, and clinical outcomes","volume":"83","author":"Y Rotman","year":"2009","journal-title":"J Virol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1089\/apc.2013.0359","article-title":"Therapeutic potential of and treatment with boceprevir\/telaprevir-based triple-therapy in HIV\/chronic hepatitis C co-infected patients in a real-world setting","volume":"28","author":"M Mandorfer","year":"2014","journal-title":"AIDS Patient Care STDS"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/S0140-6736(10)62001-6","article-title":"Increasing burden of liver disease in patients with HIV infection","volume":"377","author":"D Joshi","year":"2011","journal-title":"Lancet"},{"key":"ref17","first-page":"2117","article-title":"Is there evidence for an increase in the death rate from liver-related disease in patients with HIV?","volume":"19","author":"A Mocroft","year":"2005","journal-title":"IDS"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2893.2006.00791.x","article-title":"Liver-related mortality in human-immunodeficiency-virus-infected patients between 1995 and 2003 in the French GERMIVIC Joint Study Group Network (MORTAVIC 2003 Study)","volume":"14","author":"E Rosenthal","year":"2007","journal-title":"J Viral Hepat"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"323","DOI":"10.4254\/wjh.v5.i6.323","article-title":"Hepatocellular carcinoma in patients co-infected with hepatitis C virus and human immunodeficiency virus","volume":"5","author":"D Dimitroulis","year":"2013","journal-title":"World J Hepatol"},{"key":"ref20","first-page":"1257","article-title":"Hepatocellular carcinoma in HIV positive patients","volume":"16","author":"G Nunnari","year":"2012","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jcv.2013.01.012","article-title":"Uninodular combined hepatocellular and cholangiocarcinoma with multiple non-neoplastic hypervascular lesions appearing in the liver of a patient with HIV and HCV coinfection","volume":"57","author":"K Uchino","year":"2013","journal-title":"J Clin Virol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrgastro.2009.149","article-title":"The clinical use of HVPG measurements in chronic liver disease","volume":"6","author":"J Bosch","year":"2009","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/S0140-6736(14)60121-5","article-title":"Liver cirrhosis","volume":"383","author":"EA Tsochatzis","year":"2014","journal-title":"Lancet"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"251","DOI":"10.4254\/wjh.v2.i7.251","article-title":"Non-invasive methods for liver fibrosis prediction in hemochromatosis: One step beyond","volume":"2","author":"A Castiella","year":"2010","journal-title":"World J Hepatol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1186\/1471-2334-14-405","article-title":"Acoustic Radiation Force Impulse (ARFI) and Transient Elastography (TE) for evaluation of liver fibrosis in HIV-HCV co-infected patients","volume":"14","author":"N Frulio","year":"2014","journal-title":"BMC Infect Dis"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Yoshioka K, Hashimoto S, Kawabe N (2014) Measurement of liver stiffness as a non-invasive method for diagnosis of non-alcoholic fatty liver disease. Hepatol Res.","DOI":"10.1111\/hepr.12388"},{"key":"ref27","unstructured":"Anadol E, Schierwagen R, Elfimova N, Tack K, Schwarze-Zander C, et al. (2014) Circulating miRNAs as marker for liver injury in HIV patients. Hepatology."},{"key":"ref28","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jhep.2012.10.015","article-title":"Hepatic and serum levels of miR-122 after chronic HCV-induced fibrosis","volume":"58","author":"J Trebicka","year":"2013","journal-title":"J Hepatol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"e103779","DOI":"10.1371\/journal.pone.0103779","article-title":"The role of miRNA-34a as a prognostic biomarker for cirrhotic patients with portal hypertension receiving TIPS","volume":"9","author":"C Jansen","year":"2014","journal-title":"PLoS One"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/jgh.12362","article-title":"MicroRNA profile before and after antiviral therapy in liver transplant recipients for hepatitis C virus cirrhosis","volume":"29","author":"F Gelley","year":"2014","journal-title":"J Gastroenterol Hepatol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.1016\/j.ejca.2013.06.002","article-title":"Serum microRNA-1 and microRNA-122 are prognostic markers in patients with hepatocellular carcinoma","volume":"49","author":"V Koberle","year":"2013","journal-title":"Eur J Cancer"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s12275-014-4267-x","article-title":"The role of microRNAs in hepatitis C virus replication and related liver diseases","volume":"52","author":"CH Lee","year":"2014","journal-title":"J Microbiol"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Roderburg C, Benz F, Vargas Cardenas D, Koch A, Janssen J, et al. (2014) Elevated miR-122 serum levels are an independent marker of liver injury in inflammatory diseases. Liver Int.","DOI":"10.1111\/liv.12627"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Takaki Y, Saito Y, Takasugi A, Toshimitsu K, Yamada S, et al. (2014) Silencing of microRNA-122 is an early event during hepatocarcinogenesis from non-alcoholic steatohepatitis. Cancer Sci.","DOI":"10.1111\/cas.12498"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"e23937","DOI":"10.1371\/journal.pone.0023937","article-title":"Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease","volume":"6","author":"S Cermelli","year":"2011","journal-title":"PLoS One"},{"key":"ref36","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2011.03.002","article-title":"Portal pressure predicts outcome and safety of antiviral therapy in cirrhotic patients with hepatitis C virus infection","volume":"9","author":"T Reiberger","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1136\/gutjnl-2012-304038","article-title":"Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol","volume":"62","author":"T Reiberger","year":"2013","journal-title":"Gut"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Casu S, Berzigotti A, Abraldes JG, Baringo MA, Rocabert L, et al. (2014) A prospective observational study on tolerance and satisfaction to hepatic haemodynamic procedures. Liver Int.","DOI":"10.1111\/liv.12522"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Fernandes FF, Ferraz ML, Andrade LE, Dellavance A, Terra C, et al. (2014) Enhanced Liver Fibrosis Panel as a Predictor of Liver Fibrosis in Chronic Hepatitis C Patients. J Clin Gastroenterol.","DOI":"10.1097\/MCG.0000000000000128"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1002\/hep.25806","article-title":"von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis","volume":"56","author":"M Ferlitsch","year":"2012","journal-title":"Hepatology"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"e108544","DOI":"10.1371\/journal.pone.0108544","article-title":"PRO-C3-levels in patients with HIV\/HCV-Co-infection reflect fibrosis stage and degree of portal hypertension","volume":"9","author":"C Jansen","year":"2014","journal-title":"PLoS One"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0116768","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,18]],"date-time":"2025-05-18T08:03:03Z","timestamp":1747555383000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0116768"}},"subtitle":[],"editor":[{"given":"Matias A","family":"Avila","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,2,3]]},"references-count":41,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2015,2,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0116768","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,3]]}}}